Author:
Marlow Laura A.V.,Zimet Gregory D.,McCaffery Kirsten J.,Ostini Remo,Waller Jo
Funder
Adolescent Medicine, Department of Pediatrics, Indiana University
Cancer Research UK Health Behavior Research Center, Department of Epidemiology and Public Health, UCL
Cancer Research UK
Merck & Co.’s investigator-initiated science program (MISP)
GlaxoSmithKline
Ipswich Hospital Foundation
University of Queensland strategic research funding
National Health and Medical Research Council Career Development Fellowship
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference28 articles.
1. Against which human papillomavirus types shall we vaccinate and screen? The international perspective;Munoz;Int J Cancer,2004
2. Chapter 2: The burden of HPV-related cancers;Parkin;Vaccine,2006
3. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease;Lacey;Vaccine,2006
4. ECCA. HPV vaccination across Europe. Belgium: ECCA; April 2009.
5. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries;Wong;Vaccine,2011
Cited by
137 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献